NO995564L - Fremgangsmåte og konstruksjon for inhibisjon av cellemigrering - Google Patents

Fremgangsmåte og konstruksjon for inhibisjon av cellemigrering

Info

Publication number
NO995564L
NO995564L NO995564A NO995564A NO995564L NO 995564 L NO995564 L NO 995564L NO 995564 A NO995564 A NO 995564A NO 995564 A NO995564 A NO 995564A NO 995564 L NO995564 L NO 995564L
Authority
NO
Norway
Prior art keywords
construction
cell migration
migration inhibition
inhibition
cell
Prior art date
Application number
NO995564A
Other languages
English (en)
Other versions
NO995564D0 (no
Inventor
Paulus Hubertus Andreas Quax
Johan Hendrikus Verheijen
Original Assignee
Tno
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tno filed Critical Tno
Publication of NO995564D0 publication Critical patent/NO995564D0/no
Publication of NO995564L publication Critical patent/NO995564L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/485—Epidermal growth factor [EGF], i.e. urogastrone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8114—Kunitz type inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8114—Kunitz type inhibitors
    • C07K14/8117—Bovine/basic pancreatic trypsin inhibitor (BPTI, aprotinin)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/8146—Metalloprotease (E.C. 3.4.24) inhibitors, e.g. tissue inhibitor of metallo proteinase, TIMP
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO995564A 1997-05-12 1999-11-12 Fremgangsmåte og konstruksjon for inhibisjon av cellemigrering NO995564L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97201423 1997-05-12
PCT/NL1998/000259 WO1998051788A2 (en) 1997-05-12 1998-05-11 Method and construct for inhibition of cell migration

Publications (2)

Publication Number Publication Date
NO995564D0 NO995564D0 (no) 1999-11-12
NO995564L true NO995564L (no) 2000-01-11

Family

ID=8228315

Family Applications (1)

Application Number Title Priority Date Filing Date
NO995564A NO995564L (no) 1997-05-12 1999-11-12 Fremgangsmåte og konstruksjon for inhibisjon av cellemigrering

Country Status (7)

Country Link
EP (1) EP0981606A2 (no)
JP (1) JP2001525669A (no)
AU (1) AU7553698A (no)
CA (1) CA2289117A1 (no)
NO (1) NO995564L (no)
NZ (1) NZ500656A (no)
WO (1) WO1998051788A2 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999055365A1 (en) 1998-04-30 1999-11-04 Cornell Research Foundation, Inc. Adenoviral vectors with tandem fiber proteins
EP1112372A1 (en) 1998-09-11 2001-07-04 Genvec, Inc. Alternatively targeted adenovirus
DE10020125A1 (de) * 2000-04-18 2001-10-25 Friedrich Schiller Uni Jena Bu Agens für den postoperativen Einsatz nach Entfernung von Knochentumoren
EP1903113A1 (en) * 2000-12-18 2008-03-26 Arriva Pharmaceuticals, Inc. Multifunctional protease inhibitors and their use in treatment of disease
AU4166102A (en) * 2000-12-18 2002-07-01 Arriva Pharmaceuticals Inc Multifunctional protease inhibitors and their use in treatment of disease
US7247704B2 (en) 2000-12-18 2007-07-24 Arriva Pharmaceuticals, Inc. Multifunctional protease inhibitors and their use in treatment of disease
JP4475561B2 (ja) 2001-10-11 2010-06-09 メルク・シャープ・エンド・ドーム・コーポレイション Ｃ型肝炎ウイルスワクチン
ES2344253T3 (es) * 2001-10-11 2010-08-23 MERCK SHARP & DOHME CORP. Vacuna contra el virus de la hepatitis c.

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3856559T2 (de) * 1987-05-21 2004-04-29 Micromet Ag Multifunktionelle Proteine mit vorbestimmter Zielsetzung
US5504001A (en) * 1987-11-25 1996-04-02 Zymogenetics, Inc. Hybrid plasminogen activator
ES2085329T3 (es) * 1989-02-17 1996-06-01 Merck & Co Inc Agente anticanceroso proteico.
WO1990014363A1 (en) * 1989-05-19 1990-11-29 Amgen Inc. Metalloproteinase inhibitor
EP0404750B1 (en) * 1989-05-26 1994-08-10 Washington University Tissue inhibitor of metalloproteases (TIMP-2)
WO1991009871A1 (en) * 1989-12-22 1991-07-11 Seragen Incorporated Hybrid molecules having translocation region and cell-binding region
WO1991012328A1 (en) * 1990-02-15 1991-08-22 Fowlkes Dana M Totally synthetic affinity reagents
GB2246779B (en) * 1990-08-03 1994-08-17 Delta Biotechnology Ltd Tumour-associated protease inhibitors targeted to tumour cells
AU685187B2 (en) * 1993-10-29 1998-01-15 Incyte Pharmaceuticals, Inc. Chimeric proteins including protease nexin-1 variants
AU1176595A (en) * 1993-11-12 1995-05-29 International Technology Management Associates, Ltd. Methods of repairing connective tissues
US5550213A (en) * 1993-12-27 1996-08-27 Rutgers, The State University Of New Jersey Inhibitors of urokinase plasminogen activator
EP0739355B1 (en) * 1994-01-11 2004-09-08 Dyax Corporation Kallikrein-inhibiting "kunitz domain" proteins and analogues thereof
WO1995028955A1 (en) * 1994-04-22 1995-11-02 Gliemann Joergen PEPTIDES BINDING TO THE α2-MACROGLOBULIN RECEPTOR/LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN
US5712149A (en) * 1995-02-03 1998-01-27 Cell Genesys, Inc. Chimeric receptor molecules for delivery of co-stimulatory signals
US5843724A (en) * 1995-04-27 1998-12-01 Rutgers University Chimeric nucleic acids and proteins for inhibiting HIV-1 expression
US5726050A (en) * 1995-06-20 1998-03-10 Massachusetts Institute Of Technology Z-DNA binding protein and applications
EP0890638A4 (en) * 1996-01-08 2001-08-22 Nissin Food Products Ltd INHIBITOR OF CANCER METASAS.

Also Published As

Publication number Publication date
EP0981606A2 (en) 2000-03-01
NO995564D0 (no) 1999-11-12
JP2001525669A (ja) 2001-12-11
CA2289117A1 (en) 1998-11-19
AU7553698A (en) 1998-12-08
WO1998051788A3 (en) 1999-05-20
NZ500656A (en) 2001-11-30
WO1998051788A2 (en) 1998-11-19

Similar Documents

Publication Publication Date Title
FI102426B1 (fi) Menetelmä muistin toteuttamiseksi
FI102424B1 (fi) Menetelmä muistin toteuttamiseksi
DE69841090D1 (de) Ladungsregelungsverfahren und -vorrichtung
DK0811006T3 (da) Benzopyranholdige forbindelser og fremgangsmåde til deres anvendelse
FI962055A (fi) Pariston jatkolaite ja siihen liittyvä menetelmä
NO990110D0 (no) Prefabrikert dusjmodul og fremgangsmÕte for konstruksjon av dusj
NO973464D0 (no) Forlengingsrör - avskraperpluggapparat og fremgangsmåte
NO20003096L (no) Sammensetninger og fremgangsmÕter for behandling av ADD
NO995742L (no) Emulsjon for behandling i broenner og formasjoner
IS5158A (is) Genaraðgreinir og aðferðir
NO983366D0 (no) FremgangsmÕte og anordning for bestemmelse av banen til borehull
FI102425B1 (fi) Menetelmä muistin toteuttamiseksi
DE69838897D1 (de) Aufzeichnungsverfahren und -vorrichtung
FI970820A (fi) Jäänmurtamismenetelmä ja jäänmurtaja
FI951472A0 (fi) Radiometri ja menetelmä veden ilmaisemiseksi
NO984563D0 (no) FremgangsmÕte og blanding for inhibering av korrosjon
FI991156A0 (fi) Porausjärjestelmä ja -menetelmä
EE9900598A (et) Maksemeetod ja -süsteem
NO20001732L (no) Anordning og fremgangsmÕte for rensing av vann
NO983082L (no) FremgangsmÕte og innretning for energiutvikling
NO995564L (no) Fremgangsmåte og konstruksjon for inhibisjon av cellemigrering
DE69828227D1 (de) Aufzeichnungsverfahren
NO991577D0 (no) FremgangsmÕte og system for testing av borehull
ID18300A (id) Metoda penemperan
NO993506L (no) Rörfundament og fremgangsmÕte for tilvirkning av dette

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application